Martingale Asset Management’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Sell |
30,412
-5,300
| -15% | -$34.5K | ﹤0.01% | 759 |
|
|
2025
Q1 | $289K | Buy |
35,712
+25,412
| +247% | +$205K | 0.01% | 683 |
|
|
2024
Q4 | $127K | Sell |
10,300
-100,899
| -91% | -$1.25M | ﹤0.01% | 750 |
|
|
2024
Q3 | $912K | Buy |
111,199
+22,652
| +26% | +$186K | 0.02% | 480 |
|
|
2024
Q2 | $442K | Buy |
88,547
+19,643
| +29% | +$98K | 0.01% | 625 |
|
|
2024
Q1 | $425K | Buy |
68,904
+97
| +0.1% | +$598 | 0.01% | 645 |
|
|
2023
Q4 | $347K | Buy |
68,807
+25,190
| +58% | +$127K | 0.01% | 677 |
|
|
2023
Q3 | $251K | Buy |
+43,617
| New | +$251K | 0.01% | 717 |
|
|
2020
Q4 | – | Sell |
-62,713
| Closed | -$533K | – | 1053 |
|
|
2020
Q3 | $533K | Sell |
62,713
-77,600
| -55% | -$660K | 0.01% | 796 |
|
|
2020
Q2 | $1.46M | Buy |
+140,313
| New | +$1.46M | 0.02% | 627 |
|